Deb Hipp is a freelance health and medical writer and editor who lives in Kansas City, Missouri. She is a former investigative reporter with more than 25 years of experience as a journalist and writer ...
Calcipotriene is a generic prescription medication. It’s approved by the Food and Drug Administration (FDA) to treat psoriasis in adults. Psoriasis is an autoimmune disease, which means your immune ...
Topical ruxolitinib offers a promising treatment for dermatologic conditions with fewer adverse events than oral JAK inhibitors. FDA approvals for ruxolitinib cream in atopic dermatitis and vitiligo ...
Overview: Topical fluticasone is used to treat skin conditions that involve inflammation and itchiness, including atopic dermatitis. Common side effects from topical fluticasone are skin reactions, ...
LONG BEACH, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Dermavant Sciences, a biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, ...
LONG BEACH, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Dermavant Sciences, a biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, ...
Credit: Arcutis. Zoryve cream contains roflumilast, a phosphodiesterase type 4 inhibitor. Zoryve (roflumilast) cream 0.15% is now available for the topical treatment of mild to moderate atopic ...
If you have a fungal skin infection, your doctor may prescribe a topical form of nystatin for you. (A topical drug is applied to the skin.) Nystatin is an antifungal drug used in adults and children ...
Overview: Topical calcipotriene/betamethasone is used to treat plaque psoriasis. It has 2 different medicines in it. Calcipotriene helps slow skin cell growth to ...
Supplemental new drug application for roflumilast cream 0.15% to treat atopic dermatitis in patients 6 years of age and older was assigned a Prescription Drug User Fee Act target action date of July ...
More patients treated with Vtama achieved vIGA-AD success compared with those who received vehicle cream in both ADORING 1 (45% vs 14%) and ADORING 2 (46% vs 18%). The Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results